Management of Prostate Cancer

<p>Epidemiology and Risk Factors.- Twenty years and counting: is PSA still useful in 2010?.- Prostate Cancer Screening: A Review of the Evidence with Clinical Practice Implications.- Beyond PSA: Promising New Markers for Prostate Cancer.- Hereditary Prostate Cancer and Genetic Risk.- Prostate Inflammation and Prostate Cancer.- Molecular Progression of Prostate Cancer: Androgens and Estrogens.- The Role of Obesity and Diet in Prostate Cancer.- Prostate Cancer Risk Reduction by Chemoprevention.- Current Issues in Pathologic Evaluation.- Optimum Prostate Biopsy: Technique and Strategies.- The Utility of Nomograms in Routine Clinical Practice.- Active Surveillance Comes of Age.- Focal Therapy: Prostate Hemiablation as the First Historical Treatment Model for Focal Therapy of Early Stage Prostate Cancer.- Contemporary External Beam Radiotherapy.- Surgery, Brachytherapy, or  External Beam Radiation for Low and Intermediate-Risk Disease?.- The Role for Radical Prostatectomy in Advanced Prostate Cancer.- Radiation Therapy in the Management of Locally Advanced Prostate Cancer.- Clinical Implications of Measuring Quality-of-Life in Early Stage Prostate Cancer.- Treatment Modalities of Post-Prostatectomy Incontinence: A Historical Perspective As Well As Current  Therapy Options.- Management of Biochemical Recurrence After Localized Treatment for Prostate Cancer.- Management of Newly Diagnosed Metastatic Disease.- Pitfalls of Androgen Deprivation Therapy.- Current Management of Castration-resistant Prostate Cancer (CRPC).- Radiopharmaceuticals and Bone Metastasis.</p>